학술논문

Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection.
Document Type
Article
Source
Liver International. May2018, Vol. 38 Issue 5, p903-914. 12p. 5 Charts, 1 Graph.
Subject
*LIVER cancer patients
*LIVER injury prevention
*LIVER cancer
*CHRONIC hepatitis B
*IRON in the body
*DISEASE risk factors
Language
ISSN
1478-3223
Abstract
Abstract: Background & Aims: Hepatic iron overload is associated with liver injury and hepatocarcinogenesis; however, it has not been evaluated in patients with hepatocellular carcinoma (HCC) in Asia. The aim of this study was to clarify the degree and distribution of intrahepatic iron deposition, and their effects on the survival of HCC patients. Methods: Intrahepatic iron deposition was examined using non‐tumorous liver tissues from 204 HCC patients after curative resection, and they were scored by 2 semi‐quantitative methods: simplified Scheuer's and modified Deugnier's methods. For the Scheuer's method, iron deposition in hepatocytes and Kupffer cells was separately evaluated, while for the modified Deugnier's method, hepatocyte iron score (HIS), sinusoidal iron score (SIS) and portal iron score (PIS) were systematically evaluated, and the corrected total iron score (cTIS) was calculated by multiplying the sum (TIS) of the HIS, SIS, and PIS by the coefficient. Results: The overall prevalence of hepatic iron was 40.7% with the simplified Scheuer's method and 45.1% with the modified Deugnier's method with a mean cTIS score of 2.46. During a median follow‐up of 67 months, the cTIS was not associated with overall survival. However, a positive PIS was significantly associated with a lower 5‐year overall survival rate (50.0%) compared with a negative PIS (73.7%, P = .006). In the multivariate analysis, a positive PIS was an independent factor for overall mortality (hazard ratio, 2.310; 95% confidence interval, 1.181‐4.517). Conclusions: Intrahepatic iron deposition was common, and iron overload in the portal tract indicated poor survival in curatively resected HCC patients. [ABSTRACT FROM AUTHOR]